Phase-III human clinical trial of Oxford COVID-19 vaccine begins in Pune

The phase-III human clinical trial of the #COVID19Vaccine being developed by Oxford University, and manufactured by the Serum Institute of India (SII), began at the state-run Sassoon General Hospital here in Maharashtra on Monday, a senior official said.

Related Stories

No stories found.
The New Indian Express
www.newindianexpress.com